Cubist Systematic Strategies, LLC Soleno Therapeutics Inc Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.23 $1,118 - $2,673	-632 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.64 - $3.85 $1,036 - $2,433	632 New	632 $2,000
Q2 2019 Aug 14, 2019	SELL	$1.93 - $2.95 $28,610 - $43,730	-14,824 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.35 - $2.68 $20,012 - $39,728	14,824 New	14,824 $31,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.